Home

Find out the latest news from international oncology congresses and stay at the forefront of clinical innovation and advances in lung cancer research. Each SPECIAL ISSUE – CONGRESS REPORT features informative summaries of key topics from lung cancer to come out of a major international oncology congress.

The memo inOncology Medical education series: keeping oncologists at the forefront of lung cancer research. memo – inOncology Special Issue Preceptorship reports summarise the latest in lung cancer research and treatments to come out of our sponsored Preceptorship meeting series. The Fundamentals of Designing Clinical Trials series arms oncologists with the information they need to plan and conduct an oncology trial.

 

Anna Nowak Slider

Watch Anna Nowak discuss the latest in malignant mesothelioma research at ASCO 2017

Medical education slider

Fundamentals of designing clinical trials

Part II: Contemporary designs of phase I and II trials in oncology including endpoint selection and quality of life as an endpoint

Now available!

memo – inOncology SPECIAL ISSUE
Congress Report ASCO 2017
The latest findings in lung cancer research to come out of the ASCO congress…
Now available!

News

ASCO 2017 thumb

memo – inOncology SPECIAL ISSUE
Congress Report ASCO 2017
Highlights include a look at anti-angiogenic and immunotherapeutic treatment options for mesothelioma, the use of ctDNA NGS to suitably identify matched targeted therapies, insights into the usage of targeted agents for HER2-, ALK-, and EGFR-positive disease, and lots more…
Now available!

 

Medical education Part IIMedical education Fundamentals of designing clinical trials: Part 2: Contemporary designs of phase I and II trials in oncology including endpoint selection and quality of life as an endpoint

Sensible endpoint selection design is a critical part of oncological clinical trial design, and is explored here.  This issue looks at the usage of QOL as an endpoint, and discusses the critical aspects of…READ MORE


 

Expert interviews at ASCO

 

Richard Baird on clinical trial data for treatment of cerebral metastases, including the Cambridge brain mets trial 1 (CamBMT1) phase 1B trial data that he presented at ASCO.

Anna Nowak on malignant mesothelioma: risk factors, prognostic markers, and clinical trial data for mesothelioma treatments to come out of the congress.

Yi-Long Wu, president of the Chinese Society of Clinical Oncology, discusses his society’s collaboration with memo – inOncology, and the approval of afatinib for EGFR+ NSCLC in China.

Maya Gottfried on NSCLC screening and treatment options